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Gliosarcomas are rare bimorphic intraaxial malignant
neoplasms of the central nervous system and comprise
approximately 2% of all glioblastomas.1,2,3,4 We present a
case of gliosarcoma and review the literature of this
uncommon clinical entity.
CASE REPORT
A 69-year-old gentleman presented with a history of right-
sided weakness and slurring of speech. On examination,
he had right hemiparesis grade 4/5 (lower limb weaker
than upper limb) and slurred speech. General and
systemic examination were unremarkable. CT scan
showed a left fronto-parietal isodense lesion with marked
peripheral edema in the left frontal region; peripheral
enhancement was noted after administration of contrast
(Figure 1). On MRI the lesion was hypointense on T1- and
hyperintense on T2-weighted images, and was irregularly
enhancing with contrast. Total surgical excision was
undertaken.
Neuropathological examination revealed a malignant brain
tumour presenting a biphasic t issue pattern with
gliomatous and mesenchymal components suggestive of
gliosarcoma. The glial component was similar to a
glioblastoma, with nuclear pleomorphism, high mitotic
index, marked vascular proliferation and foci of necrosis,
either focal or geographical. Gliomatous areas showed
glial-fibrillary acidic protein expression. The mesenchymal
component consisted of areas with densely packed long
bundles of spindle cel ls in a stor i form pattern.
Immunohistochemically the cells expressed vimentin and
were surrounded by a dense network of reticulin fibres as
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ABSTRACT
Gliosarcomas are rare bimorphic intraaxial malignant neoplasms of the central nervous system. A 69-year-old gentleman
presented with a history of right-sided weakness and slurred speech. Brain imaging (CT scan and MRI) was suggestive of a
left fronto-parietal mass lesion with contrast enhancement at the periphery. Neuropathological examination revealed a
malignant brain tumour presenting a biphasic tissue pattern with gliomatous and mesenchymal components suggestive of
gliosarcoma that was further evaluated immuno¬histochemically. Although the treatment of gliosarcomas is almost similar
to glioblastomas (surgical resection and, depending on clinical status, radiotherapy and/or chemotherapy) the prognosis of
gliosarcomas remains poor.
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Figure 1 CT scan displaying an isodense lesion with marked
peripheral edema in the left frontal region (left). Peripheral
enhancement of the lesion was observed after contrast medium
injection (right)
typical features of sarcomatous cells (Figures 2-6).
Additionally, the patient received 60 Gy of radiation
therapy. 
DISCUSSION
As in the present case, gliosarcomas typically develop in
older patients. They are slightly more common in males
than females.5,6,7 Clinically, primary glioblastomas and
gliosarcomas are indistinguishable, as both variants
present with a short clinical course, low median survival
and similar peak of incidence.4,5,7 Gliosarcomas (GSa) are
characterized by a biphasic histological pattern displaying
both glial and sarcomatous components.8,9,10 
The histogenesis of GSa has been the subject of debate.
Feigin and Gross, who first described GSa, suggest that
the cel l  of or igin would arise from neoplastic
transformation of blood vessels in a preexist ing
glioblastoma.8 However, immunohistochemical studies
have fai led to detect endothel ial markers in the
sarcomatous component.11,12,13 Some studies have
shown expression of monohistiocytic markers, suggesting
that gliosarcomas develop from histiocytes, whereas
others suggest an origin from fibroblasts, pluripotent
mesenchymal cells of the perivascular adventitia, or
perivascular spaces.12,14 
The presence of identical p53 mutations and similar
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Figure 2 Photomicrograph displaying the biphasic architecture
of gliosarcoma (H&E 40X)
Figure 3 Photomicrograph displaying the biphasic architecture
of gliosarcoma (H&E 400X)
Figure 4 Photomicrograph displaying immunopositivity for PGA
(polyglycolic acid)
Figure 5 Photomicrograph displaying immunopositivity for
vimentin
chromosomal imbalances and cytogenetic alterations in
both gliomatous and sarcomatous components strongly
supports the concept of a monoclonal or igin of
gliosarcomas.5,7,10,15 
The treatment of gliosarcomas is almost similar to
glioblastomas, consisting of surgical resection and,
depending on clinical status, radiotherapy and/or
chemotherapy.1,4,11,16,17 Despite aggressive
management, prognosis of gliosarcomas remains poor.
However, a mult idiscipl inary approach (surgery,
radiotherapy and chemotherapy) seems to be associated
with slightly prolonged survival times.16,17
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Figure 6 MIB-1 staining showing high mitotic activity
